Fortress Biotech Insider Buys Signal Confidence Ahead of Regulatory Milestones
Fortress Biotech insiders buy shares at $3.10, signaling confidence ahead of potential FDA approvals, partnership deals, and value‑based reimbursement opportunities.
5 minutes to read